Global Medical Non-ionic Contrast Agent Market Growth 2026-2032
The global Medical Non-ionic Contrast Agent market size is predicted to grow from US$ 3789 million in 2025 to US$ 5820 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
A medical non-ionic contrast agent is an iodinated pharmaceutical formulation that enhances the visibility of vessels, organs and lesions during X-ray-based imaging without dissociating into charged ions in solution. The study focuses on finished sterile injectable agents based on iohexol, iopamidol, iodixanol, iopromide, ioversol and related molecules. Product differentiation is determined by iodine concentration, osmolality, viscosity, package size, injection compatibility and approved indications. The agents are used principally in computed tomography, angiography, urography and interventional radiology, where formulation quality, sterility, pharmacovigilance and reliable supply are critical.
The global average selling price in 2025 was approximately US$46 per liter
Industry capacity utilization in 2025 was approximately 83%
The industry blended gross margin in 2025 was approximately 54%
Cost structure was approximately 36% iodinated active ingredients, 4% excipients and sterile water, 11% containers and packaging, 14% aseptic filling and quality control, 8% energy and depreciation, and 27% R&D, sales and logistics
This Insight Report provides a comprehensive analysis of the global Medical Non-ionic Contrast Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Non-ionic Contrast Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Non-ionic Contrast Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Non-ionic Contrast Agent and breaks down the forecast by Motor Technology, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Non-ionic Contrast Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Non-ionic Contrast Agent market by product type, application, key manufacturers and key regions and countries.
A medical non-ionic contrast agent is an iodinated pharmaceutical formulation that enhances the visibility of vessels, organs and lesions during X-ray-based imaging without dissociating into charged ions in solution. The study focuses on finished sterile injectable agents based on iohexol, iopamidol, iodixanol, iopromide, ioversol and related molecules. Product differentiation is determined by iodine concentration, osmolality, viscosity, package size, injection compatibility and approved indications. The agents are used principally in computed tomography, angiography, urography and interventional radiology, where formulation quality, sterility, pharmacovigilance and reliable supply are critical.
Key Findings
Global sales volume in 2025 was approximately 84.2 million litersThe global average selling price in 2025 was approximately US$46 per liter
Industry capacity utilization in 2025 was approximately 83%
The industry blended gross margin in 2025 was approximately 54%
Cost structure was approximately 36% iodinated active ingredients, 4% excipients and sterile water, 11% containers and packaging, 14% aseptic filling and quality control, 8% energy and depreciation, and 27% R&D, sales and logistics
Market Trends
The long-term development of Medical Non-ionic Contrast Agent centers on lower-osmolality formulations, protocol-specific iodine concentrations, prefilled delivery formats, injector compatibility and tighter pharmacovigilance. Customer evaluation is shifting from isolated hardware specifications toward an integrated assessment of performance, reliability, software capability, maintainability and total lifecycle cost. Platform and modular design shorten customization cycles, while safety, connectivity and traceability requirements strengthen hardware-software integration. Standard products will coexist with application-specific configurations as user requirements become more segmented.Market Dynamics
Market demand is shaped by technology progress, downstream investment cycles, regulatory standards and supply-chain conditions. Buyers increasingly require verifiable performance, continuity of supply, system compatibility and responsive service, while suppliers use product platforms, regional delivery and software functions to strengthen differentiation.Drivers
rising CT and angiography procedure volumes, broader access to diagnostic imaging and expansion of interventional care are the principal market drivers. During replacement and greenfield projects, customers increasingly prioritize efficiency, safety, data-enabled management and long-term operating cost, supporting demand for reliable products and system-level solutions.Restraints
renal-risk management, hypersensitivity concerns, procurement price pressure and stringent sterile manufacturing requirements limit the pace of adoption. Purchasing decisions often require cross-functional validation, while long qualification cycles and compatibility with installed systems delay replacement. Price pressure in basic products can also constrain sustained investment in engineering and service.Opportunities
localized supply chains, differentiated concentration portfolios, prefilled containers and integrated contrast-management services represent the principal opportunities. Suppliers that provide modular products, rapid customization, remote support and compatibility with installed customer systems are better positioned to win new projects and develop recurring service revenue.Challenges
active-ingredient security, quality consistency, regulatory variation and balancing viscosity with injection performance remain core industry challenges. Suppliers must also manage component lead-time volatility, quality consistency, regional regulatory differences and inventory or service risks created by technology transitions.Industry Chain Analysis
Upstream inputs include iodinated active ingredients, pharmaceutical excipients, sterile water, glass or polymer containers and aseptic filling equipment. Midstream activities cover product design, core-component integration, manufacturing, testing, certification and software configuration. Downstream customers include hospitals, diagnostic imaging centers, catheterization laboratories and interventional radiology departments. Value creation extends beyond component performance to system compatibility, quality control, delivery responsiveness and lifecycle service.Value Chain Analysis
The value chain begins with critical materials and components and proceeds through solution design, engineering validation, scaled manufacturing, channel delivery and after-sales support. High-value activities generally concentrate in core technology, reliability validation, regulatory or industry qualification, customer-system integration and long-term maintenance, while standardized manufacturing determines cost and delivery performance.Segment Insights
Low-osmolar non-ionic monomers account for the broadest procedure coverage because they combine established protocols with multiple iodine concentrations. Iso-osmolar dimers occupy a more specialized position where clinicians prioritize osmolality management, while packaging and injector compatibility increasingly influence product selection.Downstream Market Opportunities
hospitals, diagnostic imaging centers, catheterization laboratories and interventional radiology departments are the principal demand groups. New opportunities arise from digital retrofits of installed equipment, new projects with higher safety and efficiency requirements, and system solutions that reduce labor, downtime or maintenance cost. Interface adaptation, validation support and continuing service can increase project stickiness and value per customer.Regional Insights
North America and Europe maintain high procedure intensity and strict pharmacovigilance; China is expanding domestic finished-product and active-ingredient capability; Japan favors established protocols and quality consistency; emerging markets grow with imaging-equipment penetration but remain price sensitive.Competitive Landscape Analysis
Global contrast-media specialists compete through molecule portfolios, clinical evidence, injector integration and supply reliability. Chinese pharmaceutical manufacturers strengthen their position through localized active ingredients, sterile filling capacity and hospital access, while regulatory compliance and consistent batch quality remain decisive barriers.Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Medical Non-ionic Contrast Agent Industry Forecast” looks at past sales and reviews total world Medical Non-ionic Contrast Agent sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Non-ionic Contrast Agent sales for 2026 through 2032. With Medical Non-ionic Contrast Agent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Non-ionic Contrast Agent industry.This Insight Report provides a comprehensive analysis of the global Medical Non-ionic Contrast Agent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Non-ionic Contrast Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Non-ionic Contrast Agent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Non-ionic Contrast Agent and breaks down the forecast by Motor Technology, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Non-ionic Contrast Agent.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Non-ionic Contrast Agent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Motor Technology:
- Iopamidol Injection
- Iodixanol Injection
- Iohexol Injection
- Iopromide Injection
- Other
Segmentation by Osmolality:
- Low-osmolar Non-ionic Monomer
- Iso-osmolar Non-ionic Dimer
- Other Osmolality Profiles
Segmentation by Iodine Concentration:
- <300 mg I/mL
- 300–<350 mg I/mL
- ?350 mg I/mL
Segmentation by Application:
- CT Enhanced Scan
- Neurography
- Angiography
- Arthrography
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GE HealthCare Technologies Inc. (US)
- Bracco S.p.A. (IT)
- Bayer AG (DE)
- Guerbet S.A. (FR)
- Yangtze River Pharmaceutical Group Co., Ltd. (CN)
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN)
- Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN)
- Hainan Poly Pharm Co., Ltd. (CN)
- Beijing Beilu Pharmaceutical Co., Ltd. (CN)
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Medical Non-ionic Contrast Agent market?
- What factors are driving Medical Non-ionic Contrast Agent market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Medical Non-ionic Contrast Agent market opportunities vary by end market size?
- How does Medical Non-ionic Contrast Agent break out by Motor Technology, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Non-ionic Contrast Agent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Non-ionic Contrast Agent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Non-ionic Contrast Agent by Country/Region, 2021, 2025 & 2032
2.2 Medical Non-ionic Contrast Agent Segment by Motor Technology
2.2.1 Iopamidol Injection
2.2.2 Iodixanol Injection
2.2.3 Iohexol Injection
2.2.4 Iopromide Injection
2.2.5 Other
2.2.6 Medical Non-ionic Contrast Agent Sales by Motor Technology
2.2.6.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
2.2.6.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Motor Technology (2021-2026)
2.2.6.3 Global Medical Non-ionic Contrast Agent Sale Price by Motor Technology (2021-2026)
2.3 Medical Non-ionic Contrast Agent Segment by Osmolality
2.3.1 Low-osmolar Non-ionic Monomer
2.3.2 Iso-osmolar Non-ionic Dimer
2.3.3 Other Osmolality Profiles
2.3.4 Medical Non-ionic Contrast Agent Sales by Osmolality
2.3.4.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Osmolality (2021-2026)
2.3.4.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Osmolality (2021-2026)
2.3.4.3 Global Medical Non-ionic Contrast Agent Sale Price by Osmolality (2021-2026)
2.4 Medical Non-ionic Contrast Agent Segment by Iodine Concentration
2.4.1 <300 mg I/mL
2.4.2 300–<350 mg I/mL
2.4.3 ?350 mg I/mL
2.4.4 Medical Non-ionic Contrast Agent Sales by Iodine Concentration
2.4.4.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Iodine Concentration (2021-2026)
2.4.4.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Iodine Concentration (2021-2026)
2.4.4.3 Global Medical Non-ionic Contrast Agent Sale Price by Iodine Concentration (2021-2026)
2.5 Medical Non-ionic Contrast Agent Segment by Application
2.5.1 CT Enhanced Scan
2.5.2 Neurography
2.5.3 Angiography
2.5.4 Arthrography
2.5.5 Other
2.5.6 Medical Non-ionic Contrast Agent Sales by Application
2.5.6.1 Global Medical Non-ionic Contrast Agent Sale Market Share by Application (2021-2026)
2.5.6.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Medical Non-ionic Contrast Agent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Non-ionic Contrast Agent Breakdown Data by Company
3.1.1 Global Medical Non-ionic Contrast Agent Annual Sales by Company (2021-2026)
3.1.2 Global Medical Non-ionic Contrast Agent Sales Market Share by Company (2021-2026)
3.2 Global Medical Non-ionic Contrast Agent Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Non-ionic Contrast Agent Revenue by Company (2021-2026)
3.2.2 Global Medical Non-ionic Contrast Agent Revenue Market Share by Company (2021-2026)
3.3 Global Medical Non-ionic Contrast Agent Sale Price by Company
3.4 Key Manufacturers Medical Non-ionic Contrast Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Non-ionic Contrast Agent Product Location Distribution
3.4.2 Players Medical Non-ionic Contrast Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL NON-IONIC CONTRAST AGENT BY GEOGRAPHIC REGION
4.1 World Historic Medical Non-ionic Contrast Agent Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Non-ionic Contrast Agent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Non-ionic Contrast Agent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Non-ionic Contrast Agent Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Non-ionic Contrast Agent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Non-ionic Contrast Agent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Non-ionic Contrast Agent Sales Growth
4.4 APAC Medical Non-ionic Contrast Agent Sales Growth
4.5 Europe Medical Non-ionic Contrast Agent Sales Growth
4.6 Middle East & Africa Medical Non-ionic Contrast Agent Sales Growth
5 AMERICAS
5.1 Americas Medical Non-ionic Contrast Agent Sales by Country
5.1.1 Americas Medical Non-ionic Contrast Agent Sales by Country (2021-2026)
5.1.2 Americas Medical Non-ionic Contrast Agent Revenue by Country (2021-2026)
5.2 Americas Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
5.3 Americas Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Non-ionic Contrast Agent Sales by Region
6.1.1 APAC Medical Non-ionic Contrast Agent Sales by Region (2021-2026)
6.1.2 APAC Medical Non-ionic Contrast Agent Revenue by Region (2021-2026)
6.2 APAC Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
6.3 APAC Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Non-ionic Contrast Agent by Country
7.1.1 Europe Medical Non-ionic Contrast Agent Sales by Country (2021-2026)
7.1.2 Europe Medical Non-ionic Contrast Agent Revenue by Country (2021-2026)
7.2 Europe Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
7.3 Europe Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Non-ionic Contrast Agent by Country
8.1.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Non-ionic Contrast Agent Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
8.3 Middle East & Africa Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Non-ionic Contrast Agent
10.3 Manufacturing Process Analysis of Medical Non-ionic Contrast Agent
10.4 Industry Chain Structure of Medical Non-ionic Contrast Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Non-ionic Contrast Agent Distributors
11.3 Medical Non-ionic Contrast Agent Customer
12 WORLD FORECAST REVIEW FOR MEDICAL NON-IONIC CONTRAST AGENT BY GEOGRAPHIC REGION
12.1 Global Medical Non-ionic Contrast Agent Market Size Forecast by Region
12.1.1 Global Medical Non-ionic Contrast Agent Forecast by Region (2027-2032)
12.1.2 Global Medical Non-ionic Contrast Agent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Non-ionic Contrast Agent Forecast by Motor Technology (2027-2032)
12.7 Global Medical Non-ionic Contrast Agent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE HealthCare Technologies Inc. (US)
13.1.1 GE HealthCare Technologies Inc. (US) Company Information
13.1.2 GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.1.3 GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE HealthCare Technologies Inc. (US) Main Business Overview
13.1.5 GE HealthCare Technologies Inc. (US) Latest Developments
13.2 Bracco S.p.A. (IT)
13.2.1 Bracco S.p.A. (IT) Company Information
13.2.2 Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.2.3 Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bracco S.p.A. (IT) Main Business Overview
13.2.5 Bracco S.p.A. (IT) Latest Developments
13.3 Bayer AG (DE)
13.3.1 Bayer AG (DE) Company Information
13.3.2 Bayer AG (DE) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.3.3 Bayer AG (DE) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer AG (DE) Main Business Overview
13.3.5 Bayer AG (DE) Latest Developments
13.4 Guerbet S.A. (FR)
13.4.1 Guerbet S.A. (FR) Company Information
13.4.2 Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.4.3 Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Guerbet S.A. (FR) Main Business Overview
13.4.5 Guerbet S.A. (FR) Latest Developments
13.5 Yangtze River Pharmaceutical Group Co., Ltd. (CN)
13.5.1 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Company Information
13.5.2 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.5.3 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Main Business Overview
13.5.5 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Latest Developments
13.6 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN)
13.6.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Company Information
13.6.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.6.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Main Business Overview
13.6.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Latest Developments
13.7 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN)
13.7.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Company Information
13.7.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Main Business Overview
13.7.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Latest Developments
13.8 Hainan Poly Pharm Co., Ltd. (CN)
13.8.1 Hainan Poly Pharm Co., Ltd. (CN) Company Information
13.8.2 Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.8.3 Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hainan Poly Pharm Co., Ltd. (CN) Main Business Overview
13.8.5 Hainan Poly Pharm Co., Ltd. (CN) Latest Developments
13.9 Beijing Beilu Pharmaceutical Co., Ltd. (CN)
13.9.1 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Company Information
13.9.2 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.9.3 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Main Business Overview
13.9.5 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Non-ionic Contrast Agent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Non-ionic Contrast Agent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Non-ionic Contrast Agent by Country/Region, 2021, 2025 & 2032
2.2 Medical Non-ionic Contrast Agent Segment by Motor Technology
2.2.1 Iopamidol Injection
2.2.2 Iodixanol Injection
2.2.3 Iohexol Injection
2.2.4 Iopromide Injection
2.2.5 Other
2.2.6 Medical Non-ionic Contrast Agent Sales by Motor Technology
2.2.6.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
2.2.6.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Motor Technology (2021-2026)
2.2.6.3 Global Medical Non-ionic Contrast Agent Sale Price by Motor Technology (2021-2026)
2.3 Medical Non-ionic Contrast Agent Segment by Osmolality
2.3.1 Low-osmolar Non-ionic Monomer
2.3.2 Iso-osmolar Non-ionic Dimer
2.3.3 Other Osmolality Profiles
2.3.4 Medical Non-ionic Contrast Agent Sales by Osmolality
2.3.4.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Osmolality (2021-2026)
2.3.4.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Osmolality (2021-2026)
2.3.4.3 Global Medical Non-ionic Contrast Agent Sale Price by Osmolality (2021-2026)
2.4 Medical Non-ionic Contrast Agent Segment by Iodine Concentration
2.4.1 <300 mg I/mL
2.4.2 300–<350 mg I/mL
2.4.3 ?350 mg I/mL
2.4.4 Medical Non-ionic Contrast Agent Sales by Iodine Concentration
2.4.4.1 Global Medical Non-ionic Contrast Agent Sales Market Share by Iodine Concentration (2021-2026)
2.4.4.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Iodine Concentration (2021-2026)
2.4.4.3 Global Medical Non-ionic Contrast Agent Sale Price by Iodine Concentration (2021-2026)
2.5 Medical Non-ionic Contrast Agent Segment by Application
2.5.1 CT Enhanced Scan
2.5.2 Neurography
2.5.3 Angiography
2.5.4 Arthrography
2.5.5 Other
2.5.6 Medical Non-ionic Contrast Agent Sales by Application
2.5.6.1 Global Medical Non-ionic Contrast Agent Sale Market Share by Application (2021-2026)
2.5.6.2 Global Medical Non-ionic Contrast Agent Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Medical Non-ionic Contrast Agent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Non-ionic Contrast Agent Breakdown Data by Company
3.1.1 Global Medical Non-ionic Contrast Agent Annual Sales by Company (2021-2026)
3.1.2 Global Medical Non-ionic Contrast Agent Sales Market Share by Company (2021-2026)
3.2 Global Medical Non-ionic Contrast Agent Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Non-ionic Contrast Agent Revenue by Company (2021-2026)
3.2.2 Global Medical Non-ionic Contrast Agent Revenue Market Share by Company (2021-2026)
3.3 Global Medical Non-ionic Contrast Agent Sale Price by Company
3.4 Key Manufacturers Medical Non-ionic Contrast Agent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Non-ionic Contrast Agent Product Location Distribution
3.4.2 Players Medical Non-ionic Contrast Agent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL NON-IONIC CONTRAST AGENT BY GEOGRAPHIC REGION
4.1 World Historic Medical Non-ionic Contrast Agent Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Non-ionic Contrast Agent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Non-ionic Contrast Agent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Non-ionic Contrast Agent Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Non-ionic Contrast Agent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Non-ionic Contrast Agent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Non-ionic Contrast Agent Sales Growth
4.4 APAC Medical Non-ionic Contrast Agent Sales Growth
4.5 Europe Medical Non-ionic Contrast Agent Sales Growth
4.6 Middle East & Africa Medical Non-ionic Contrast Agent Sales Growth
5 AMERICAS
5.1 Americas Medical Non-ionic Contrast Agent Sales by Country
5.1.1 Americas Medical Non-ionic Contrast Agent Sales by Country (2021-2026)
5.1.2 Americas Medical Non-ionic Contrast Agent Revenue by Country (2021-2026)
5.2 Americas Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
5.3 Americas Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Non-ionic Contrast Agent Sales by Region
6.1.1 APAC Medical Non-ionic Contrast Agent Sales by Region (2021-2026)
6.1.2 APAC Medical Non-ionic Contrast Agent Revenue by Region (2021-2026)
6.2 APAC Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
6.3 APAC Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Non-ionic Contrast Agent by Country
7.1.1 Europe Medical Non-ionic Contrast Agent Sales by Country (2021-2026)
7.1.2 Europe Medical Non-ionic Contrast Agent Revenue by Country (2021-2026)
7.2 Europe Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
7.3 Europe Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Non-ionic Contrast Agent by Country
8.1.1 Middle East & Africa Medical Non-ionic Contrast Agent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Non-ionic Contrast Agent Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026)
8.3 Middle East & Africa Medical Non-ionic Contrast Agent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Non-ionic Contrast Agent
10.3 Manufacturing Process Analysis of Medical Non-ionic Contrast Agent
10.4 Industry Chain Structure of Medical Non-ionic Contrast Agent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Non-ionic Contrast Agent Distributors
11.3 Medical Non-ionic Contrast Agent Customer
12 WORLD FORECAST REVIEW FOR MEDICAL NON-IONIC CONTRAST AGENT BY GEOGRAPHIC REGION
12.1 Global Medical Non-ionic Contrast Agent Market Size Forecast by Region
12.1.1 Global Medical Non-ionic Contrast Agent Forecast by Region (2027-2032)
12.1.2 Global Medical Non-ionic Contrast Agent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Non-ionic Contrast Agent Forecast by Motor Technology (2027-2032)
12.7 Global Medical Non-ionic Contrast Agent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 GE HealthCare Technologies Inc. (US)
13.1.1 GE HealthCare Technologies Inc. (US) Company Information
13.1.2 GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.1.3 GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 GE HealthCare Technologies Inc. (US) Main Business Overview
13.1.5 GE HealthCare Technologies Inc. (US) Latest Developments
13.2 Bracco S.p.A. (IT)
13.2.1 Bracco S.p.A. (IT) Company Information
13.2.2 Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.2.3 Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bracco S.p.A. (IT) Main Business Overview
13.2.5 Bracco S.p.A. (IT) Latest Developments
13.3 Bayer AG (DE)
13.3.1 Bayer AG (DE) Company Information
13.3.2 Bayer AG (DE) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.3.3 Bayer AG (DE) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bayer AG (DE) Main Business Overview
13.3.5 Bayer AG (DE) Latest Developments
13.4 Guerbet S.A. (FR)
13.4.1 Guerbet S.A. (FR) Company Information
13.4.2 Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.4.3 Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Guerbet S.A. (FR) Main Business Overview
13.4.5 Guerbet S.A. (FR) Latest Developments
13.5 Yangtze River Pharmaceutical Group Co., Ltd. (CN)
13.5.1 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Company Information
13.5.2 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.5.3 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Main Business Overview
13.5.5 Yangtze River Pharmaceutical Group Co., Ltd. (CN) Latest Developments
13.6 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN)
13.6.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Company Information
13.6.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.6.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Main Business Overview
13.6.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Latest Developments
13.7 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN)
13.7.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Company Information
13.7.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.7.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Main Business Overview
13.7.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Latest Developments
13.8 Hainan Poly Pharm Co., Ltd. (CN)
13.8.1 Hainan Poly Pharm Co., Ltd. (CN) Company Information
13.8.2 Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.8.3 Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hainan Poly Pharm Co., Ltd. (CN) Main Business Overview
13.8.5 Hainan Poly Pharm Co., Ltd. (CN) Latest Developments
13.9 Beijing Beilu Pharmaceutical Co., Ltd. (CN)
13.9.1 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Company Information
13.9.2 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
13.9.3 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Main Business Overview
13.9.5 Beijing Beilu Pharmaceutical Co., Ltd. (CN) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Non-ionic Contrast Agent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Non-ionic Contrast Agent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Iopamidol Injection
Table 4. Major Players of Iodixanol Injection
Table 5. Major Players of Iohexol Injection
Table 6. Major Players of Iopromide Injection
Table 7. Major Players of Other
Table 8. Global Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 9. Global Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Table 10. Global Medical Non-ionic Contrast Agent Revenue by Motor Technology (2021-2026) & ($ million)
Table 11. Global Medical Non-ionic Contrast Agent Revenue Market Share by Motor Technology (2021-2026)
Table 12. Global Medical Non-ionic Contrast Agent Sale Price by Motor Technology (2021-2026) & (US$/Liter)
Table 13. Major Players of Low-osmolar Non-ionic Monomer
Table 14. Major Players of Iso-osmolar Non-ionic Dimer
Table 15. Major Players of Other Osmolality Profiles
Table 16. Global Medical Non-ionic Contrast Agent Sales by Osmolality (2021-2026) & (K Liters)
Table 17. Global Medical Non-ionic Contrast Agent Sales Market Share by Osmolality (2021-2026)
Table 18. Global Medical Non-ionic Contrast Agent Revenue by Osmolality (2021-2026) & ($ million)
Table 19. Global Medical Non-ionic Contrast Agent Revenue Market Share by Osmolality (2021-2026)
Table 20. Global Medical Non-ionic Contrast Agent Sale Price by Osmolality (2021-2026) & (US$/Liter)
Table 21. Major Players of <300 mg I/mL
Table 22. Major Players of 300–<350 mg I/mL
Table 23. Major Players of ?350 mg I/mL
Table 24. Global Medical Non-ionic Contrast Agent Sales by Iodine Concentration (2021-2026) & (K Liters)
Table 25. Global Medical Non-ionic Contrast Agent Sales Market Share by Iodine Concentration (2021-2026)
Table 26. Global Medical Non-ionic Contrast Agent Revenue by Iodine Concentration (2021-2026) & ($ million)
Table 27. Global Medical Non-ionic Contrast Agent Revenue Market Share by Iodine Concentration (2021-2026)
Table 28. Global Medical Non-ionic Contrast Agent Sale Price by Iodine Concentration (2021-2026) & (US$/Liter)
Table 29. Global Medical Non-ionic Contrast Agent Sale by Application (2021-2026) & (K Liters)
Table 30. Global Medical Non-ionic Contrast Agent Sale Market Share by Application (2021-2026)
Table 31. Global Medical Non-ionic Contrast Agent Revenue by Application (2021-2026) & ($ million)
Table 32. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application (2021-2026)
Table 33. Global Medical Non-ionic Contrast Agent Sale Price by Application (2021-2026) & (US$/Liter)
Table 34. Global Medical Non-ionic Contrast Agent Sales by Company (2021-2026) & (K Liters)
Table 35. Global Medical Non-ionic Contrast Agent Sales Market Share by Company (2021-2026)
Table 36. Global Medical Non-ionic Contrast Agent Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Medical Non-ionic Contrast Agent Revenue Market Share by Company (2021-2026)
Table 38. Global Medical Non-ionic Contrast Agent Sale Price by Company (2021-2026) & (US$/Liter)
Table 39. Key Manufacturers Medical Non-ionic Contrast Agent Producing Area Distribution and Sales Area
Table 40. Players Medical Non-ionic Contrast Agent Products Offered
Table 41. Medical Non-ionic Contrast Agent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Medical Non-ionic Contrast Agent Sales by Geographic Region (2021-2026) & (K Liters)
Table 45. Global Medical Non-ionic Contrast Agent Sales Market Share Geographic Region (2021-2026)
Table 46. Global Medical Non-ionic Contrast Agent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Medical Non-ionic Contrast Agent Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Medical Non-ionic Contrast Agent Sales by Country/Region (2021-2026) & (K Liters)
Table 49. Global Medical Non-ionic Contrast Agent Sales Market Share by Country/Region (2021-2026)
Table 50. Global Medical Non-ionic Contrast Agent Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Medical Non-ionic Contrast Agent Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Medical Non-ionic Contrast Agent Sales by Country (2021-2026) & (K Liters)
Table 53. Americas Medical Non-ionic Contrast Agent Sales Market Share by Country (2021-2026)
Table 54. Americas Medical Non-ionic Contrast Agent Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 56. Americas Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 57. APAC Medical Non-ionic Contrast Agent Sales by Region (2021-2026) & (K Liters)
Table 58. APAC Medical Non-ionic Contrast Agent Sales Market Share by Region (2021-2026)
Table 59. APAC Medical Non-ionic Contrast Agent Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 61. APAC Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 62. Europe Medical Non-ionic Contrast Agent Sales by Country (2021-2026) & (K Liters)
Table 63. Europe Medical Non-ionic Contrast Agent Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 65. Europe Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 66. Middle East & Africa Medical Non-ionic Contrast Agent Sales by Country (2021-2026) & (K Liters)
Table 67. Middle East & Africa Medical Non-ionic Contrast Agent Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 69. Middle East & Africa Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 70. Key Market Drivers & Growth Opportunities of Medical Non-ionic Contrast Agent
Table 71. Key Market Challenges & Risks of Medical Non-ionic Contrast Agent
Table 72. Key Industry Trends of Medical Non-ionic Contrast Agent
Table 73. Medical Non-ionic Contrast Agent Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Medical Non-ionic Contrast Agent Distributors List
Table 76. Medical Non-ionic Contrast Agent Customer List
Table 77. Global Medical Non-ionic Contrast Agent Sales Forecast by Region (2027-2032) & (K Liters)
Table 78. Global Medical Non-ionic Contrast Agent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Medical Non-ionic Contrast Agent Sales Forecast by Country (2027-2032) & (K Liters)
Table 80. Americas Medical Non-ionic Contrast Agent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Medical Non-ionic Contrast Agent Sales Forecast by Region (2027-2032) & (K Liters)
Table 82. APAC Medical Non-ionic Contrast Agent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Medical Non-ionic Contrast Agent Sales Forecast by Country (2027-2032) & (K Liters)
Table 84. Europe Medical Non-ionic Contrast Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Medical Non-ionic Contrast Agent Sales Forecast by Country (2027-2032) & (K Liters)
Table 86. Middle East & Africa Medical Non-ionic Contrast Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Medical Non-ionic Contrast Agent Sales Forecast by Motor Technology (2027-2032) & (K Liters)
Table 88. Global Medical Non-ionic Contrast Agent Revenue Forecast by Motor Technology (2027-2032) & ($ millions)
Table 89. Global Medical Non-ionic Contrast Agent Sales Forecast by Application (2027-2032) & (K Liters)
Table 90. Global Medical Non-ionic Contrast Agent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. GE HealthCare Technologies Inc. (US) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 92. GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 93. GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 94. GE HealthCare Technologies Inc. (US) Main Business
Table 95. GE HealthCare Technologies Inc. (US) Latest Developments
Table 96. Bracco S.p.A. (IT) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 97. Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 98. Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 99. Bracco S.p.A. (IT) Main Business
Table 100. Bracco S.p.A. (IT) Latest Developments
Table 101. Bayer AG (DE) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 102. Bayer AG (DE) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 103. Bayer AG (DE) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 104. Bayer AG (DE) Main Business
Table 105. Bayer AG (DE) Latest Developments
Table 106. Guerbet S.A. (FR) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 107. Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 108. Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 109. Guerbet S.A. (FR) Main Business
Table 110. Guerbet S.A. (FR) Latest Developments
Table 111. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 112. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 113. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 114. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Main Business
Table 115. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Latest Developments
Table 116. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 117. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 118. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 119. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Main Business
Table 120. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Latest Developments
Table 121. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 122. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 123. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 124. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Main Business
Table 125. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Latest Developments
Table 126. Hainan Poly Pharm Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 127. Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 128. Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 129. Hainan Poly Pharm Co., Ltd. (CN) Main Business
Table 130. Hainan Poly Pharm Co., Ltd. (CN) Latest Developments
Table 131. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 132. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 133. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 134. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Main Business
Table 135. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Latest Developments
Table 1. Medical Non-ionic Contrast Agent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Non-ionic Contrast Agent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Iopamidol Injection
Table 4. Major Players of Iodixanol Injection
Table 5. Major Players of Iohexol Injection
Table 6. Major Players of Iopromide Injection
Table 7. Major Players of Other
Table 8. Global Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 9. Global Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Table 10. Global Medical Non-ionic Contrast Agent Revenue by Motor Technology (2021-2026) & ($ million)
Table 11. Global Medical Non-ionic Contrast Agent Revenue Market Share by Motor Technology (2021-2026)
Table 12. Global Medical Non-ionic Contrast Agent Sale Price by Motor Technology (2021-2026) & (US$/Liter)
Table 13. Major Players of Low-osmolar Non-ionic Monomer
Table 14. Major Players of Iso-osmolar Non-ionic Dimer
Table 15. Major Players of Other Osmolality Profiles
Table 16. Global Medical Non-ionic Contrast Agent Sales by Osmolality (2021-2026) & (K Liters)
Table 17. Global Medical Non-ionic Contrast Agent Sales Market Share by Osmolality (2021-2026)
Table 18. Global Medical Non-ionic Contrast Agent Revenue by Osmolality (2021-2026) & ($ million)
Table 19. Global Medical Non-ionic Contrast Agent Revenue Market Share by Osmolality (2021-2026)
Table 20. Global Medical Non-ionic Contrast Agent Sale Price by Osmolality (2021-2026) & (US$/Liter)
Table 21. Major Players of <300 mg I/mL
Table 22. Major Players of 300–<350 mg I/mL
Table 23. Major Players of ?350 mg I/mL
Table 24. Global Medical Non-ionic Contrast Agent Sales by Iodine Concentration (2021-2026) & (K Liters)
Table 25. Global Medical Non-ionic Contrast Agent Sales Market Share by Iodine Concentration (2021-2026)
Table 26. Global Medical Non-ionic Contrast Agent Revenue by Iodine Concentration (2021-2026) & ($ million)
Table 27. Global Medical Non-ionic Contrast Agent Revenue Market Share by Iodine Concentration (2021-2026)
Table 28. Global Medical Non-ionic Contrast Agent Sale Price by Iodine Concentration (2021-2026) & (US$/Liter)
Table 29. Global Medical Non-ionic Contrast Agent Sale by Application (2021-2026) & (K Liters)
Table 30. Global Medical Non-ionic Contrast Agent Sale Market Share by Application (2021-2026)
Table 31. Global Medical Non-ionic Contrast Agent Revenue by Application (2021-2026) & ($ million)
Table 32. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application (2021-2026)
Table 33. Global Medical Non-ionic Contrast Agent Sale Price by Application (2021-2026) & (US$/Liter)
Table 34. Global Medical Non-ionic Contrast Agent Sales by Company (2021-2026) & (K Liters)
Table 35. Global Medical Non-ionic Contrast Agent Sales Market Share by Company (2021-2026)
Table 36. Global Medical Non-ionic Contrast Agent Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Medical Non-ionic Contrast Agent Revenue Market Share by Company (2021-2026)
Table 38. Global Medical Non-ionic Contrast Agent Sale Price by Company (2021-2026) & (US$/Liter)
Table 39. Key Manufacturers Medical Non-ionic Contrast Agent Producing Area Distribution and Sales Area
Table 40. Players Medical Non-ionic Contrast Agent Products Offered
Table 41. Medical Non-ionic Contrast Agent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Medical Non-ionic Contrast Agent Sales by Geographic Region (2021-2026) & (K Liters)
Table 45. Global Medical Non-ionic Contrast Agent Sales Market Share Geographic Region (2021-2026)
Table 46. Global Medical Non-ionic Contrast Agent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Medical Non-ionic Contrast Agent Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Medical Non-ionic Contrast Agent Sales by Country/Region (2021-2026) & (K Liters)
Table 49. Global Medical Non-ionic Contrast Agent Sales Market Share by Country/Region (2021-2026)
Table 50. Global Medical Non-ionic Contrast Agent Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Medical Non-ionic Contrast Agent Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Medical Non-ionic Contrast Agent Sales by Country (2021-2026) & (K Liters)
Table 53. Americas Medical Non-ionic Contrast Agent Sales Market Share by Country (2021-2026)
Table 54. Americas Medical Non-ionic Contrast Agent Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 56. Americas Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 57. APAC Medical Non-ionic Contrast Agent Sales by Region (2021-2026) & (K Liters)
Table 58. APAC Medical Non-ionic Contrast Agent Sales Market Share by Region (2021-2026)
Table 59. APAC Medical Non-ionic Contrast Agent Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 61. APAC Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 62. Europe Medical Non-ionic Contrast Agent Sales by Country (2021-2026) & (K Liters)
Table 63. Europe Medical Non-ionic Contrast Agent Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 65. Europe Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 66. Middle East & Africa Medical Non-ionic Contrast Agent Sales by Country (2021-2026) & (K Liters)
Table 67. Middle East & Africa Medical Non-ionic Contrast Agent Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Medical Non-ionic Contrast Agent Sales by Motor Technology (2021-2026) & (K Liters)
Table 69. Middle East & Africa Medical Non-ionic Contrast Agent Sales by Application (2021-2026) & (K Liters)
Table 70. Key Market Drivers & Growth Opportunities of Medical Non-ionic Contrast Agent
Table 71. Key Market Challenges & Risks of Medical Non-ionic Contrast Agent
Table 72. Key Industry Trends of Medical Non-ionic Contrast Agent
Table 73. Medical Non-ionic Contrast Agent Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Medical Non-ionic Contrast Agent Distributors List
Table 76. Medical Non-ionic Contrast Agent Customer List
Table 77. Global Medical Non-ionic Contrast Agent Sales Forecast by Region (2027-2032) & (K Liters)
Table 78. Global Medical Non-ionic Contrast Agent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Medical Non-ionic Contrast Agent Sales Forecast by Country (2027-2032) & (K Liters)
Table 80. Americas Medical Non-ionic Contrast Agent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Medical Non-ionic Contrast Agent Sales Forecast by Region (2027-2032) & (K Liters)
Table 82. APAC Medical Non-ionic Contrast Agent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Medical Non-ionic Contrast Agent Sales Forecast by Country (2027-2032) & (K Liters)
Table 84. Europe Medical Non-ionic Contrast Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Medical Non-ionic Contrast Agent Sales Forecast by Country (2027-2032) & (K Liters)
Table 86. Middle East & Africa Medical Non-ionic Contrast Agent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Medical Non-ionic Contrast Agent Sales Forecast by Motor Technology (2027-2032) & (K Liters)
Table 88. Global Medical Non-ionic Contrast Agent Revenue Forecast by Motor Technology (2027-2032) & ($ millions)
Table 89. Global Medical Non-ionic Contrast Agent Sales Forecast by Application (2027-2032) & (K Liters)
Table 90. Global Medical Non-ionic Contrast Agent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. GE HealthCare Technologies Inc. (US) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 92. GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 93. GE HealthCare Technologies Inc. (US) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 94. GE HealthCare Technologies Inc. (US) Main Business
Table 95. GE HealthCare Technologies Inc. (US) Latest Developments
Table 96. Bracco S.p.A. (IT) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 97. Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 98. Bracco S.p.A. (IT) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 99. Bracco S.p.A. (IT) Main Business
Table 100. Bracco S.p.A. (IT) Latest Developments
Table 101. Bayer AG (DE) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 102. Bayer AG (DE) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 103. Bayer AG (DE) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 104. Bayer AG (DE) Main Business
Table 105. Bayer AG (DE) Latest Developments
Table 106. Guerbet S.A. (FR) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 107. Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 108. Guerbet S.A. (FR) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 109. Guerbet S.A. (FR) Main Business
Table 110. Guerbet S.A. (FR) Latest Developments
Table 111. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 112. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 113. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 114. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Main Business
Table 115. Yangtze River Pharmaceutical Group Co., Ltd. (CN) Latest Developments
Table 116. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 117. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 118. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 119. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Main Business
Table 120. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) Latest Developments
Table 121. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 122. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 123. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 124. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Main Business
Table 125. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) Latest Developments
Table 126. Hainan Poly Pharm Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 127. Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 128. Hainan Poly Pharm Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 129. Hainan Poly Pharm Co., Ltd. (CN) Main Business
Table 130. Hainan Poly Pharm Co., Ltd. (CN) Latest Developments
Table 131. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Basic Information, Medical Non-ionic Contrast Agent Manufacturing Base, Sales Area and Its Competitors
Table 132. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Product Portfolios and Specifications
Table 133. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Medical Non-ionic Contrast Agent Sales (K Liters), Revenue ($ Million), Price (US$/Liter) and Gross Margin (2021-2026)
Table 134. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Main Business
Table 135. Beijing Beilu Pharmaceutical Co., Ltd. (CN) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Non-ionic Contrast Agent
Figure 2. Medical Non-ionic Contrast Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Non-ionic Contrast Agent Sales Growth Rate 2021-2032 (K Liters)
Figure 7. Global Medical Non-ionic Contrast Agent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Non-ionic Contrast Agent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Non-ionic Contrast Agent Sales Market Share by Country/Region (2025)
Figure 10. Medical Non-ionic Contrast Agent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Iopamidol Injection
Figure 12. Product Picture of Iodixanol Injection
Figure 13. Product Picture of Iohexol Injection
Figure 14. Product Picture of Iopromide Injection
Figure 15. Product Picture of Other
Figure 16. Global Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology in 2026
Figure 17. Global Medical Non-ionic Contrast Agent Revenue Market Share by Motor Technology (2021-2026)
Figure 18. Product Picture of Low-osmolar Non-ionic Monomer
Figure 19. Product Picture of Iso-osmolar Non-ionic Dimer
Figure 20. Product Picture of Other Osmolality Profiles
Figure 21. Global Medical Non-ionic Contrast Agent Sales Market Share by Osmolality in 2026
Figure 22. Global Medical Non-ionic Contrast Agent Revenue Market Share by Osmolality (2021-2026)
Figure 23. Product Picture of <300 mg I/mL
Figure 24. Product Picture of 300–<350 mg I/mL
Figure 25. Product Picture of ?350 mg I/mL
Figure 26. Global Medical Non-ionic Contrast Agent Sales Market Share by Iodine Concentration in 2026
Figure 27. Global Medical Non-ionic Contrast Agent Revenue Market Share by Iodine Concentration (2021-2026)
Figure 28. Medical Non-ionic Contrast Agent Consumed in CT Enhanced Scan
Figure 29. Global Medical Non-ionic Contrast Agent Market: CT Enhanced Scan (2021-2026) & (K Liters)
Figure 30. Medical Non-ionic Contrast Agent Consumed in Neurography
Figure 31. Global Medical Non-ionic Contrast Agent Market: Neurography (2021-2026) & (K Liters)
Figure 32. Medical Non-ionic Contrast Agent Consumed in Angiography
Figure 33. Global Medical Non-ionic Contrast Agent Market: Angiography (2021-2026) & (K Liters)
Figure 34. Medical Non-ionic Contrast Agent Consumed in Arthrography
Figure 35. Global Medical Non-ionic Contrast Agent Market: Arthrography (2021-2026) & (K Liters)
Figure 36. Medical Non-ionic Contrast Agent Consumed in Other
Figure 37. Global Medical Non-ionic Contrast Agent Market: Other (2021-2026) & (K Liters)
Figure 38. Global Medical Non-ionic Contrast Agent Sale Market Share by Application (2025)
Figure 39. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application in 2025
Figure 40. Medical Non-ionic Contrast Agent Sales by Company in 2025 (K Liters)
Figure 41. Global Medical Non-ionic Contrast Agent Sales Market Share by Company in 2025
Figure 42. Medical Non-ionic Contrast Agent Revenue by Company in 2025 ($ millions)
Figure 43. Global Medical Non-ionic Contrast Agent Revenue Market Share by Company in 2025
Figure 44. Global Medical Non-ionic Contrast Agent Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Medical Non-ionic Contrast Agent Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 47. Americas Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 48. APAC Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 49. APAC Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 50. Europe Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 51. Europe Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 53. Middle East & Africa Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 54. Americas Medical Non-ionic Contrast Agent Sales Market Share by Country in 2025
Figure 55. Americas Medical Non-ionic Contrast Agent Revenue Market Share by Country (2021-2026)
Figure 56. Americas Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 57. Americas Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 58. United States Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Medical Non-ionic Contrast Agent Sales Market Share by Region in 2025
Figure 63. APAC Medical Non-ionic Contrast Agent Revenue Market Share by Region (2021-2026)
Figure 64. APAC Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 65. APAC Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 66. China Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 70. India Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Medical Non-ionic Contrast Agent Sales Market Share by Country in 2025
Figure 74. Europe Medical Non-ionic Contrast Agent Revenue Market Share by Country (2021-2026)
Figure 75. Europe Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 76. Europe Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 77. Germany Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 78. France Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Medical Non-ionic Contrast Agent Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 84. Middle East & Africa Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 85. Egypt Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Medical Non-ionic Contrast Agent in 2026
Figure 91. Manufacturing Process Analysis of Medical Non-ionic Contrast Agent
Figure 92. Industry Chain Structure of Medical Non-ionic Contrast Agent
Figure 93. Channels of Distribution
Figure 94. Global Medical Non-ionic Contrast Agent Sales Market Forecast by Region (2027-2032)
Figure 95. Global Medical Non-ionic Contrast Agent Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Medical Non-ionic Contrast Agent Sales Market Share Forecast by Motor Technology (2027-2032)
Figure 97. Global Medical Non-ionic Contrast Agent Revenue Market Share Forecast by Motor Technology (2027-2032)
Figure 98. Global Medical Non-ionic Contrast Agent Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Medical Non-ionic Contrast Agent Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Non-ionic Contrast Agent
Figure 2. Medical Non-ionic Contrast Agent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Non-ionic Contrast Agent Sales Growth Rate 2021-2032 (K Liters)
Figure 7. Global Medical Non-ionic Contrast Agent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Non-ionic Contrast Agent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Non-ionic Contrast Agent Sales Market Share by Country/Region (2025)
Figure 10. Medical Non-ionic Contrast Agent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Iopamidol Injection
Figure 12. Product Picture of Iodixanol Injection
Figure 13. Product Picture of Iohexol Injection
Figure 14. Product Picture of Iopromide Injection
Figure 15. Product Picture of Other
Figure 16. Global Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology in 2026
Figure 17. Global Medical Non-ionic Contrast Agent Revenue Market Share by Motor Technology (2021-2026)
Figure 18. Product Picture of Low-osmolar Non-ionic Monomer
Figure 19. Product Picture of Iso-osmolar Non-ionic Dimer
Figure 20. Product Picture of Other Osmolality Profiles
Figure 21. Global Medical Non-ionic Contrast Agent Sales Market Share by Osmolality in 2026
Figure 22. Global Medical Non-ionic Contrast Agent Revenue Market Share by Osmolality (2021-2026)
Figure 23. Product Picture of <300 mg I/mL
Figure 24. Product Picture of 300–<350 mg I/mL
Figure 25. Product Picture of ?350 mg I/mL
Figure 26. Global Medical Non-ionic Contrast Agent Sales Market Share by Iodine Concentration in 2026
Figure 27. Global Medical Non-ionic Contrast Agent Revenue Market Share by Iodine Concentration (2021-2026)
Figure 28. Medical Non-ionic Contrast Agent Consumed in CT Enhanced Scan
Figure 29. Global Medical Non-ionic Contrast Agent Market: CT Enhanced Scan (2021-2026) & (K Liters)
Figure 30. Medical Non-ionic Contrast Agent Consumed in Neurography
Figure 31. Global Medical Non-ionic Contrast Agent Market: Neurography (2021-2026) & (K Liters)
Figure 32. Medical Non-ionic Contrast Agent Consumed in Angiography
Figure 33. Global Medical Non-ionic Contrast Agent Market: Angiography (2021-2026) & (K Liters)
Figure 34. Medical Non-ionic Contrast Agent Consumed in Arthrography
Figure 35. Global Medical Non-ionic Contrast Agent Market: Arthrography (2021-2026) & (K Liters)
Figure 36. Medical Non-ionic Contrast Agent Consumed in Other
Figure 37. Global Medical Non-ionic Contrast Agent Market: Other (2021-2026) & (K Liters)
Figure 38. Global Medical Non-ionic Contrast Agent Sale Market Share by Application (2025)
Figure 39. Global Medical Non-ionic Contrast Agent Revenue Market Share by Application in 2025
Figure 40. Medical Non-ionic Contrast Agent Sales by Company in 2025 (K Liters)
Figure 41. Global Medical Non-ionic Contrast Agent Sales Market Share by Company in 2025
Figure 42. Medical Non-ionic Contrast Agent Revenue by Company in 2025 ($ millions)
Figure 43. Global Medical Non-ionic Contrast Agent Revenue Market Share by Company in 2025
Figure 44. Global Medical Non-ionic Contrast Agent Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Medical Non-ionic Contrast Agent Revenue Market Share by Geographic Region in 2025
Figure 46. Americas Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 47. Americas Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 48. APAC Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 49. APAC Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 50. Europe Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 51. Europe Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Medical Non-ionic Contrast Agent Sales 2021-2026 (K Liters)
Figure 53. Middle East & Africa Medical Non-ionic Contrast Agent Revenue 2021-2026 ($ millions)
Figure 54. Americas Medical Non-ionic Contrast Agent Sales Market Share by Country in 2025
Figure 55. Americas Medical Non-ionic Contrast Agent Revenue Market Share by Country (2021-2026)
Figure 56. Americas Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 57. Americas Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 58. United States Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Medical Non-ionic Contrast Agent Sales Market Share by Region in 2025
Figure 63. APAC Medical Non-ionic Contrast Agent Revenue Market Share by Region (2021-2026)
Figure 64. APAC Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 65. APAC Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 66. China Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 70. India Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Medical Non-ionic Contrast Agent Sales Market Share by Country in 2025
Figure 74. Europe Medical Non-ionic Contrast Agent Revenue Market Share by Country (2021-2026)
Figure 75. Europe Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 76. Europe Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 77. Germany Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 78. France Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Medical Non-ionic Contrast Agent Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Medical Non-ionic Contrast Agent Sales Market Share by Motor Technology (2021-2026)
Figure 84. Middle East & Africa Medical Non-ionic Contrast Agent Sales Market Share by Application (2021-2026)
Figure 85. Egypt Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Medical Non-ionic Contrast Agent Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Medical Non-ionic Contrast Agent in 2026
Figure 91. Manufacturing Process Analysis of Medical Non-ionic Contrast Agent
Figure 92. Industry Chain Structure of Medical Non-ionic Contrast Agent
Figure 93. Channels of Distribution
Figure 94. Global Medical Non-ionic Contrast Agent Sales Market Forecast by Region (2027-2032)
Figure 95. Global Medical Non-ionic Contrast Agent Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Medical Non-ionic Contrast Agent Sales Market Share Forecast by Motor Technology (2027-2032)
Figure 97. Global Medical Non-ionic Contrast Agent Revenue Market Share Forecast by Motor Technology (2027-2032)
Figure 98. Global Medical Non-ionic Contrast Agent Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Medical Non-ionic Contrast Agent Revenue Market Share Forecast by Application (2027-2032)
